Pathway Financial Advisers’s Xylem XYL Stock Holding History

Pathway Financial Advisers’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.61M	Sell	13,583 -199	-1%	-$23K	0.4%	82
2026 Q1	$1.65M	Buy	13,782 +1,909	+16%	+$250K	0.47%	76
2025 Q4	$1.62M	Buy	11,873 +653	+6%	+$93.9K	0.47%	74
2025 Q3	$1.65M	Buy	11,220 +4,841	+76%	+$671K	0.48%	72
2025 Q2	$825K	Buy	6,379 +685	+12%	+$83K	0.27%	103
2025 Q1	$680K	Buy	5,694 +5,376	+1,691%	+$666K	0.23%	107
2024 Q4	$36.9K	Buy	318 +175	+122%	+$22.1K	0.01%	257
2024 Q3	$19.3K	Hold	143	–	–	0.01%	253
2024 Q2	$19.3K	Buy	143 +1	+0.7%	+$136	0.01%	296
2024 Q1	$18.4K	Hold	142	–	–	0.01%	297
2023 Q4	$16.2K	Buy	142 +1	+0.7%	+$100	0.01%	313
2023 Q3	$12.9K	Buy	+141	New	+$14.5K	0.01%	336
2023 Q1	$19.2K	Hold	183	–	–	0.01%	313
2022 Q4	$20.2K	Buy	+183	New	+$19.2K	0.01%	333

Other funds holding XYL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Pathway Financial Advisers's XYL Position: Q2 2026 in Review

Pathway Financial Advisers reduced its Xylem (XYL) stake by 1.4% in Q2 2026, selling an estimated $23K and leaving 13,583 shares worth $1.61M. The position accounts for 0.4% of the portfolio, ranked #82.

Pathway Financial Advisers first reported a position in XYL in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.65M in Q3 2025. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

Pathway Financial Advisers held 13,583 shares of Xylem worth $1.61M as of Q2 2026.
Pathway Financial Advisers sold 199 Xylem shares in Q2 2026, an estimated $23K.
Xylem made up 0.4% of Pathway Financial Advisers's portfolio in Q2 2026, its #82 holding.
Pathway Financial Advisers first reported a position in Xylem in Q4 2022 and has held it in 14 quarters since.
Pathway Financial Advisers's Xylem position peaked at $1.65M in Q3 2025.
1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Pathway Financial Advisers's 13F filing for Q2 2026, filed 30 Jul 2026.